Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer
Sandro Porceddu(Peter MacCallum Cancer Centre), Lester J. Peters(Peter MacCallum Cancer Centre), Danny Rischin(Peter MacCallum Cancer Centre), Rodney J. Hicks(Flinders Medical Centre), Robert S. Ware(The University of Queensland), Elizabeth Jarmolowski(Peter MacCallum Cancer Centre), LeAnn Weih(Peter MacCallum Cancer Centre), June Corry(St Vincent's Hospital Melbourne)
Cited by 257
Related Papers
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|1990|1.4k
Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships
|International Journal of Radiation Oncology*Biology*Physics|1982|842
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
|Journal of Clinical Oncology|2010|741
Prognostic Significance of [<sup>18</sup>F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02
|Journal of Clinical Oncology|2006|543